Clinical Trials on Adnexal Pathology in Australia

Total 7408 results

Princess Margaret Hospital for Children

Completed

Safety Study of Home Oxygen Therapy for Children With Acute Bronchiolitis

Bronchiolitis

Australia
GlaxoSmithKline

Terminated

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Infections, Bacterial

Australia
Athos Therapeutics Inc
Syneos Health; Athos Therapeutics Australia Pty Ltd

Completed

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Autoimmune Diseases | Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Australia
Cocrystal Pharma, Inc.
Cocrystal Pharma Australia Pty Ltd.; Linear Clinical Research

Completed

CC-42344 Safety Study in Healthy Participants

Influenza A

Australia
GPN Vaccines

Recruiting

Extension Safety and Immunogenicity Study of GPNV-001

Pneumococcal Infections

Australia
Sir Charles Gairdner Hospital
The University of Western Australia

Terminated

The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients

Peritoneal Dialysis | Peritoneal Dialysis, Continuous Ambulatory

Australia
University of South Australia

Completed

Hypnotic Intervention for Women With Chronic Pelvic Pain

Chronic Pain | Pelvic Pain | Psychological | Hypnosis, Animal

Australia
GlaxoSmithKline

Completed

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

Irritable Bowel Syndrome

Australia
GlaxoSmithKline

Completed

A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects

Irritable Bowel Syndrome

Australia
University of Adelaide

Completed

Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)

Individuals at Risk of Developing Diabetes

Australia
Serum Institute of India Pvt. Ltd.
PPD

Completed

Safety Study of Dengushield in Healthy Adults

Dengue | Phase 1

Australia
Royal Adelaide Hospital
Merck Sharp & Dohme LLC

Completed

Effects of Sitagliptin on Gastric Emptying in Healthy Subjects

Diabetes Mellitus | Gastroparesis

Australia
Gmax Biopharm Australia Pty Ltd.

Completed

Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106

Overweight and Obesity

Australia
GlaxoSmithKline

Completed

To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

Healthy Subjects | Infections, Bacterial

Australia
La Trobe University
The Alfred

Completed

Evaluation of Bedside Methods to Measure Muscularity in Critically Ill Patients

Critical Illness

Australia
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
Sanofi
Regeneron Pharmaceuticals

Completed

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Ovarian Neoplasms | Ascites

United States, Canada, Spain, India, Belgium, Austria, Hungary, Israel, United Kingdom
Austin Health

Unknown

Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation (CHLORIDE)

Shock | Critical Illness

Australia
SIMR (Australia) Biotech Pty Ltd.

Completed

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

Peripheral Neuropathic Pain

Australia
PharmAbcine

Active, not recruiting

TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma

Recurrent Glioblastoma

Australia
National Ageing Research Institute, Australia

Unknown

RCT to Reduce Further Falls and Injuries for Older Fallers Presenting to an Emergency Department

Accidental Falls

Australia
GPN Vaccines

Recruiting

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Pneumococcal Infections

Australia
Xalud Therapeutics, Inc.

Completed

Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain

Osteoarthritis, Knee

Australia
GlaxoSmithKline

Completed

A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers

Irritable Bowel Syndrome

Australia
The University of Western Australia
Royal Perth Hospital; Hollywood Private Hospital

Completed

Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne

Acne

Australia
Clover Biopharmaceuticals AUS Pty Ltd

Completed

SCB-2019 as COVID-19 Vaccine

COVID-19

Australia
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

Respiratory Disorders

Australia
Monash University
Curtin University; Flinders University; Ambulance Victoria; SA Ambulance Service; St John Ambulance Australia (Western Australia)

Unknown

Reduction of Oxygen After Cardiac Arrest (EXACT)

Out-of-Hospital Cardiac Arrest

Australia
University of Adelaide

Completed

Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (IMPART)

Diabetes | Metabolic Syndrome

Australia
Resverlogix Corp
South Australian Health and Medical Research Institute

Terminated

Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

Coronary Artery Disease | Dyslipidemia

Australia
Singapore General Hospital

Recruiting

A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula (PREDATOR)

Dialysis Access Malfunction | Neointimal Hyperplasia

Singapore, Australia
Royal Perth Hospital

Recruiting

Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans (EMPA-SNS)

Obesity | Type 2 Diabetes Mellitus | Metabolic Syndrome

Australia
Boehringer Ingelheim

Completed

A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

Pulmonary Disease, Chronic Obstructive

Australia, New Zealand, United Kingdom
The University of Western Australia
Royal Brisbane and Women's Hospital; Fremantle Hospital and Health Service; Royal... and other collaborators

Completed

Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis

Ulcerative Colitis

Australia
Vaxine Pty Ltd
Central Adelaide Local Health Network Incorporated

Completed

Monovalent Recombinant COVID19 Vaccine (COVAX19)

Coronavirus Infection | COVID

Australia
University of Adelaide

Completed

Hyperbaric Oxygen Treatment Ameliorates Insulin Resistance (HOTAIR)

Obesity | Type 2 Diabetes

Australia
FertilitySA
University of Adelaide

Completed

EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage (BlastGen)

Infertility | Recurrent Miscarriage

Australia
Biogen

Completed

Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants

Sciatica

Australia
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Department of Health, Western Australia

Completed

Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu

Upper Respiratory Tract Infections

Australia
Fremantle Hospital and Health Service

Completed

In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia

Hepatitis C

Australia
AstraZeneca

Completed

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Australia
Pharmosa Biopharm Inc.
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

Pulmonary Arterial Hypertension

Australia
Australian and New Zealand Intensive Care Research...
Melbourne Health; Royal Adelaide Hospital; Auckland City Hospital; The Canberra...

Completed

TARGET-Metabolic Effects (TARGET-ME)

Critical Illness | Enteral Nutrition

Australia
Melbourne Health

Completed

Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.

Critically Ill

Australia
Mage Biologics
Alimentiv Inc.

Recruiting

A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants

Ulcerative Colitis

Australia
ResMed
The University of Western Australia

Completed

AutoSet for Her Clinical Trial Protocol

Obstructive Sleep Apnea

Australia
Monash University
National Health and Medical Research Council, Australia; Cerebral Palsy Alliance and other collaborators

Recruiting

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction (PROTECTMe)

Fetal Growth Retardation | Pregnancy Preterm | Stillbirth and Fetal Death

Australia, New Zealand
University of Adelaide
SA Health

Completed

South Australian Meningococcal B Vaccine Herd Immunity Study (B Part of It)

Meningococcal Disease

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
UMC Utrecht
M.D. Anderson Cancer Center; University Health Network, Toronto; University of... and other collaborators

Completed

Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis

Primary Aldosteronism | Primary Aldosteronism Due to Aldosterone Producing Adenoma | Primary Aldosteronism Due to Conn Adenoma

United States, Netherlands, Australia, Canada, Italy

Clinical Trials on Adnexal Pathology in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations